Please select the option that best describes you:
Topics:
Hematologic Malignancies • Medical Oncology • Internal Medicine • Myeloproliferative Neoplasms • Hematology • Benign Hematology
Would you consider using HMA in management of polycythemia vera?
i.e. treatment-refractory PV, prior to progression to PMF or AML
Answer from: Medical Oncologist at Academic Institution
The short answer is no. However, it depends on what is going on with the patient and what is meant by refractory? If one is managing symptomatic PV or trying to control counts then hydroxyurea, pegylated interferons, and ruxolitinib are the available options and it is worth mentioning that ropeginte...
Sign in or Register to read more